Refine by
Lyra Sinusitis Equipment & Supplies
1 equipment items found
Manufactured by:Lyra Therapeutics, Inc. based inWatertown, MASSACHUSETTS (USA)
Lyra’s lead product candidate, LYR-210, to treat chronic rhinosinusitis (CRS), an inflammatory disease of the paranasal sinuses. LYR-210 is an anti-inflammatory implantable drug matrix based upon Lyra’s XTreo™ platform designed to elute mometasone furoate consistently and locally to the inflamed mucosal tissue of surgically-naïve CRS patients for up to ...